Observational studyCancer reports (Hoboken, N.J.)2022

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study.

Lincy S Lal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.